A detailed history of Financial Advocates Investment Management transactions in Amgen Inc stock. As of the latest transaction made, Financial Advocates Investment Management holds 15,385 shares of AMGN stock, worth $4.85 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
15,385
Previous 500 2977.0%
Holding current value
$4.85 Million
Previous $156,000 3077.56%
% of portfolio
0.28%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$309.38 - $337.38 $168,612 - $183,872
545 Added 3.67%
15,385 $4.96 Million
Q2 2024

Jul 26, 2024

BUY
$262.75 - $319.31 $1.61 Million - $1.96 Million
6,124 Added 70.26%
14,840 $4.64 Million
Q1 2024

May 01, 2024

BUY
$268.87 - $324.56 $11,023 - $13,306
41 Added 0.47%
8,716 $2.48 Million
Q4 2023

Feb 08, 2024

BUY
$255.7 - $288.46 $130,662 - $147,403
511 Added 6.26%
8,675 $2.5 Million
Q3 2023

Oct 27, 2023

BUY
$218.65 - $271.46 $60,784 - $75,465
278 Added 3.53%
8,164 $2.19 Million
Q2 2023

Aug 07, 2023

BUY
$214.27 - $253.37 $271,694 - $321,273
1,268 Added 19.16%
7,886 $1.75 Million
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $290,817 - $354,457
1,288 Added 24.17%
6,618 $1.6 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $663,957 - $843,637
2,899 Added 119.25%
5,330 $1.4 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $506,157 - $570,853
-2,255 Reduced 48.12%
2,431 $542,000
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $439,502 - $489,089
1,905 Added 68.5%
4,686 $1.14 Million
Q1 2022

May 11, 2022

SELL
$219.27 - $242.57 $1,973 - $2,183
-9 Reduced 0.32%
2,781 $673,000
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $64,039 - $73,287
-322 Reduced 10.35%
2,790 $628,000
Q3 2021

Nov 04, 2021

BUY
$212.27 - $248.7 $49,246 - $57,698
232 Added 8.06%
3,112 $662,000
Q2 2021

Aug 03, 2021

BUY
$233.58 - $259.14 $40,409 - $44,831
173 Added 6.39%
2,880 $702,000
Q1 2021

May 10, 2021

SELL
$221.91 - $258.6 $348,620 - $406,260
-1,571 Reduced 36.72%
2,707 $674,000
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $47,387 - $56,429
219 Added 5.4%
4,278 $983,000
Q3 2020

Nov 04, 2020

SELL
$234.65 - $260.95 $4,693 - $5,219
-20 Reduced 0.49%
4,059 $1.03 Million
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $12,659 - $15,535
64 Added 1.59%
4,079 $962,000
Q1 2020

Apr 29, 2020

SELL
$182.24 - $241.7 $25,695 - $34,079
-141 Reduced 3.39%
4,015 $814,000
Q4 2019

Feb 13, 2020

SELL
$189.21 - $243.2 $48,626 - $62,502
-257 Reduced 5.82%
4,156 $1 Million
Q3 2019

Nov 13, 2019

BUY
$174.11 - $208.62 $8,531 - $10,222
49 Added 1.12%
4,413 $846,000
Q2 2019

Aug 08, 2019

SELL
$166.7 - $195.41 $72,181 - $84,612
-433 Reduced 9.03%
4,364 $804,000
Q1 2019

May 16, 2019

BUY
$180.87 - $203.88 $51,728 - $58,309
286 Added 6.34%
4,797 $911,000
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $387,306 - $452,110
-2,171 Reduced 32.49%
4,511 $878,000
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $65,963 - $74,364
356 Added 5.63%
6,682 $0
Q2 2018

Aug 09, 2018

BUY
$166.05 - $186.51 $103,449 - $116,195
623 Added 10.92%
6,326 $1.17 Million
Q1 2018

May 11, 2018

SELL
$169.43 - $198.0 $43,204 - $50,490
-255 Reduced 4.28%
5,703 $972,000
Q4 2017

Feb 15, 2018

BUY
$168.79 - $188.59 $1.01 Million - $1.12 Million
5,958
5,958 $1.04 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Financial Advocates Investment Management Portfolio

Follow Financial Advocates Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advocates Investment Management with notifications on news.